title: [Enoxaparin dosage in extreme obesity by monitoring anti-Xa factor].
authors.affiliation: Servicio de Farmacia, Hospital General Universitario de Elche.. arantxa.ambg@gmail.com.
authors.forename: Arantxa
authors.initials: A
authors.lastname: Andújar Mateos
authors.affiliation: Servicio de Farmacia, Hospital General Universitario de Elche.. arantxa.ambg@gmail.com.
authors.forename: Carmen
authors.initials: C
authors.lastname: Matoses Chirivella
authors.affiliation: Servicio de Farmacia, Hospital General Universitario de Elche.. arantxa.ambg@gmail.com.
authors.forename: Francisco José
authors.initials: FJ
authors.lastname: Rodríguez Lucena
authors.affiliation: Servicio de Farmacia, Hospital General Universitario de Elche.. arantxa.ambg@gmail.com.
authors.forename: Andrés
authors.initials: A
authors.lastname: Navarro Ruiz
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D015951:Factor Xa / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009767:Obesity, Morbid / Q000097:blood / Q000150:complications*; D013923:Thromboembolism / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D015951:Factor Xa